Skip to main content

Year: 2024

Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that data from an interim analysis of the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC) will be featured during a poster session at the upcoming 25th Annual Meeting of the Society of Urologic Oncology (SUO) taking place December 4, 2024 to December 6, 2024, in Dallas, Texas. The presentation will include safety data featured in the abstract published today on the SUO website, as well as updated safety and new efficacy data from approximately 20 enrolled patients, the majority of whom are six-month evaluable. ADVANCED-2 (NCT05951179) is a Phase 2 open-label...

Continue reading

RecycLiCo Announces Annual General Meeting to be Held on December 12, 2024

SURREY, British Columbia, Nov. 15, 2024 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”), TSX.V: AMY, OTCQB: AMYZF, FSE: ID4, a pioneer in sustainable lithium-ion battery recycling technology, is pleased to announce that its annual general meeting (the “AGM”) will be held on Thursday, December 12, 2024, at 1:00 p.m. (Vancouver time) at the Executive Hotel Vancouver Airport, Executive Board Room, 7311 Westminster Hwy, Richmond, BC, V6X 1A3. Meeting Details and Proxy MaterialsShareholders are encouraged to review the proxy materials, which have been mailed to all shareholders of record. Proxy materials are also available for download on the Company’s website at www.recyclico.com/agm and on SEDAR+ for those who did not receive them via mail. Shareholders are reminded to submit their proxies or voting...

Continue reading

ERES REIT Declares November 2024 Monthly Distribution

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — European Residential Real Estate Investment Trust (TSX: ERE.UN, “ERES”) is pleased to announce that the trustees of ERES have declared the November 2024 monthly cash distribution of €0.01 per Unit and Class B LP Unit (the “November Distribution”), being equivalent to €0.12 per Unit annualized. The distribution will be payable to holders of the Units and Class B LP Units (the “Unitholders”) of record on November 29, 2024, with payment on December 16, 2024. The Euro-denominated distribution will be paid in Canadian dollars based on the exchange rate on the date of payment (estimated C$0.01477 per Unit and Class B LP Unit). Registered Unitholders will be provided with an option to elect to receive such distribution in Euros rather than Canadian dollars. If no such election is made, registered...

Continue reading

CAPREIT Announces November 2024 Distribution

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX: CAR.UN) announced today its November 2024 monthly distribution in the amount of $0.125 per Unit (or $1.50 on an annualized basis). The November 2024 distribution will be payable on December 16, 2024 to Unitholders of record at the close of business on November 29, 2024. CAPREIT is Canada’s largest publicly traded provider of quality rental housing. As at September 30, 2024, CAPREIT owns approximately 63,400 residential apartment suites, townhomes and manufactured home community sites, including approximately 15,400 suites and sites classified as assets held for sale, that are well-located across Canada and the Netherlands, with a total fair value of approximately $16.9 billion, including approximately $1.9 billion...

Continue reading

Nobel Announces Results of AGM

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Nobel Resources Corp. (TSX–V: NBLC; OTCQB: NBTRF) (the “Company” or “Nobel”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Nobel held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. Nobel management would like to thank shareholders for their participation and continuing support. About Nobel Nobel Resources is a Canadian resource...

Continue reading

Peyto Exploration & Development Corp. Confirms Monthly Dividend for December 13, 2024

CALGARY, Alberta, Nov. 15, 2024 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (TSX: PEY) (“Peyto”) confirms that the monthly dividend with respect to November 2024 of $0.11 per common share is to be paid on December 13, 2024, for shareholders of record on November 30, 2024. Dividends paid by Peyto to Canadian residents are eligible dividends for Canadian income tax purposes. Shareholders and interested investors are encouraged to visit the Peyto website at www.peyto.com to learn more about what makes Peyto one of North America’s most exciting energy companies. The website also includes a monthly report, which discusses various topics chosen by the President and CEO and includes estimates of monthly capital expenditures and production. For further information please contact: Jean-Paul LachancePresident...

Continue reading

Halcones Precious Metals Announces AGM Results

TORONTO, Nov. 15, 2024 (GLOBE NEWSWIRE) — Halcones Precious Metals Corp. (TSXV: HPM) (the “Company” or “Halcones”) is pleased to report that the nominees listed in the management proxy circular dated October 4, 2024 (the “Circular”) for the annual and special meeting of shareholders of Halcones held on November 15, 2024 (the “Meeting”) were elected as directors of the Company.  The appointment of each of the nominees to the Company’s board was approved by more than 99% of the votes cast at the Meeting.  Shareholders at the Meeting also approved the appointment of the Company’s auditors, the Company’s stock option plan and the Company’s restricted share unit and deferred unit plan. Details of these plans are included in the Circular which is available under the Company’s profile on SEDAR+ at www.sedarplus.ca. Halcones management...

Continue reading

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has notified The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to file its own Form 25 (Notification of Removal of Listing) with the U.S. Securities and Exchange Commission (the “SEC”) to complete the previously-disclosed process to delist the Company’s common stock, par value $0.001 per share (the “Common Stock”), from the Nasdaq Global Market in advance of Nasdaq’s anticipated filing of a Form 25 with the SEC. As previously disclosed, the Common Stock was suspended from trading on Nasdaq as of October 3, 2024, pursuant to a final delisting notice sent to the Company by the Listing Qualifications Department of Nasdaq due to the Company’s inability to regain compliance...

Continue reading

China Green Agriculture, Inc. (CGA) Changes Name to Enlightify Inc.

XI’AN, CHINA, Nov. 15, 2024 (GLOBE NEWSWIRE) — China Green Agriculture, Inc. (NYSE: CGA) has changed its name to Enlightify Inc., effective November 25, 2024. Its ticker symbol will change to ENFY effective November 25, 2024, and it is expected to begin trading under that symbol on November 26, 2024. The Company mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China. About China Green Agriculture, Inc. The Company produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its wholly owned subsidiaries, i.e.: Shaanxi TechTeam Jinong Humic Acid Product Co., Ltd. (“Jinong”), Beijing Gufeng Chemical Products Co., Ltd (“Gufeng”) and variable...

Continue reading

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to seven new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on November 12, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4). In the aggregate, the new non-executive employees received options to purchase 495,000 shares of Annexon common stock. The options carry a ten-year term and an exercise price per share equal to $6.12, which was the closing price of Annexon’s common stock on November 15, 2024, the date grant of, and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.